Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Plasma cell 1Lymphoid 1

Conditions

Venous Thromboembolism 2Venous Thrombosis 1Thrombosis 1Sarcoma 1Pulmonary Embolism 1Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Lymphoma 1Fractures, Spontaneous 1Femoral Fractures 1Bone Neoplasms 1

Interventions

Ifosfamide 8Doxorubicin 8Blood Specimen Collection 8Radiosurgery 7Proton Therapy 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Standard of Care 4Radiotherapy 4Magnetic Resonance Spectroscopy 4X-Rays 3Vincristine 3Radiation Dose Hypofractionation 3Palliative Care 3Methods 3Mesna 3pegfilgrastim 2pazopanib 2dexamethasone acetate 2Trastuzumab 2Transurethral Resection of Bladder 2Restraint, Physical 2Radiotherapy, Intensity-Modulated 2Protons 2Practice Guidelines as Topic 2Neoadjuvant Therapy 2Methotrexate 2Melphalan 2Heavy Ion Radiotherapy 2Gene Expression Profiling 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Sarcoma × Dalteparin × Clear all
NCT00525057 2021-01-22

Dalteparin in Preventing DVT in Participants With Cancer

M.D. Anderson Cancer Center

Phase NA Completed
65 enrolled 14 charts
LymphoidPlasma cellSarcoma

Bone Neoplasms, Femoral Fractures, Fractures, Spontaneous, Lymphoma, Multiple Myeloma, Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡